Mrna Production Co-Op
Northeastern University Students
Posted on 11/9/2023
Chroma Medicine

51-200 employees

Pioneering single-dose genomic medicines using epigenetics
Company Overview
Chroma Medicine is a pioneer in the field of genomic medicine, leveraging the power of epigenetics to develop single-dose treatments that precisely control gene activity without altering the DNA sequence. Their work is based on groundbreaking research from leading genomic medicine experts, giving them a competitive edge in the development of a new class of therapeutics. This focus on precision genomics and commitment to curing diseases makes Chroma Medicine an exciting and rewarding place to work.
Biotechnology
B2B

Company Stage

Series B

Total Funding

$260M

Founded

2021

Headquarters

Boston, Massachusetts

Growth & Insights
Headcount

6 month growth

22%

1 year growth

74%

2 year growth

269%
Locations
Cambridge, MA, USA
Experience Level
Intern
CategoriesNew
Medical, Clinical & Veterinary
Biology & Biotech
Requirements
  • Currently enrolled as an undergraduate or graduate student majoring in Biology/Chemistry or other life-sciences related disciplines
  • 1+ years of relevant co-op or internship experience
  • Experience with PCR, aseptic technique, chemical synthesis, gel electrophoresis
  • Strong attention to detail
  • Eligible to work in the United States
Responsibilities
  • Learn the of Chroma’s In Vitro Transcription (IVT) based mRNA production process including:
  • laboratory automation related to IVT production and sample aliquoting.
  • analytical instrumentation related to IVT product purity and integrity characterization.
  • Interface with the plasmid production / procurement group to source IVT template materials.
  • Maintain crucial reagent and consumables stocks as well as keeping detailed records of IVT batch production.
  • Develop and execute research proposals to test and improve existing high throughput IVT protocols.
  • Work with other groups within the organization to translate research-grade material production protocols into downstream ready processes.